Supplementary Fig. S2 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
التفاصيل البيبلوغرافية
العنوان:
Supplementary Fig. S2 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Assessment of HER2 copy number dispersion. A, The Gini coefficient measuring the dispersion of HER2/CEP17 ratio in each patient. P-value is from a Kolmogorov-Smirnov test. B, Association between the Gini coefficient and Shan-non equitability index in each patient. R and p-value are from a Pearson correlation test of association. C, Association between the Gini coefficient and percent of HER2 non-amplified cells in each patient. R and p-value are from a Pearson correlation test of association. A-C, Red represents patients without pCR and blue represents patients with pCR.
